Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,773 across all filing types
Latest filing 2020-11-11 Declaration of Voting R…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by a legal entity (Morgan Stanley) in Evotec SE, referencing specific German securities laws (WpHG Articles 40 and 33/34). This content directly aligns with the definition of reporting changes in significant share ownership thresholds. Reviewing the filing definitions: - 10-K/IR: Not a full annual or interim financial report. - ER: Not an earnings release. - CT: Not a call transcript. - The key phrase is 'Notification of Major Holdings' and the content details voting rights percentages and instruments held by a shareholder. - Definition 20 (MRQ - Major Shareholding Notification) covers 'Notification of changes in significant share ownership levels (crossing thresholds)'. This is the most precise fit.
2020-11-11 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections detailing the 'Notification of Major Holdings' under German securities law (WpHG). It reports changes in the percentage of voting rights held by Morgan Stanley in Evotec SE, crossing or reaching specific thresholds. This directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which aligns best with the Major Shareholding Notification category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the content is a formal disclosure of shareholding changes, not the results of a vote (DVA).
2020-11-06 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' under German Securities Trading Act (WpHG). It reports changes in voting rights percentages held by Morgan Stanley, crossing specific thresholds (0.52% direct, 12.74% instruments, 13.26% total). This content directly corresponds to the reporting of changes in significant share ownership, which aligns perfectly with the definition for Major Shareholding Notification (MRQ). Although it is disseminated via DGAP (which could suggest RNS), the specific content dictates the MRQ classification over the general regulatory fallback.
2020-11-05 English
EVOTEC SE TO ANNOUNCE RESULTS FOR THE FIRST NINE MONTHS 2020 ON 12 NOVEMBER 2020
Report Publication Announcement Classification · 99% confidence The document is a news release dated November 5, 2020, announcing that Evotec SE will release its financial results for the first nine months of 2020 on November 12, 2020. It provides details for an upcoming conference call and webcast. Since this document is an announcement *about* the future release of financial results (specifically an interim report), and not the comprehensive report itself, it fits the definition of a Report Publication Announcement (RPA). It is not the Interim Report (IR) itself, nor is it a general Earnings Release (ER) which typically contains the actual results highlights. The document explicitly states the date the results will be announced, fitting the RPA description.
2020-11-05 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' under German Securities Trading Act (WpHG). It reports changes in voting rights percentages held by Morgan Stanley in Evotec SE, crossing or reaching specific thresholds. This directly corresponds to the definition of reporting changes in significant share ownership levels, which aligns best with the Major Shareholding Notification category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, MRQ is the specific regulatory filing type for tracking these ownership changes, whereas DVA is for the *results* of a shareholder vote.
2020-11-04 English
EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES
Report Publication Announcement Classification · 99% confidence The document is a corporate news release announcing that Evotec SE management will be presenting at several upcoming investor conferences between November and December 2020. This type of announcement, detailing participation in investor events (like the Consilium Healthcare Conference, German Equity Forum, etc.), is a standard form of investor relations communication. It is not a full financial report (10-K, IR), an earnings release (ER), or a transcript (CT). It is a general announcement intended for investors regarding future engagement opportunities. Since there is no specific category for 'Investor Conference Schedule Announcement,' the most appropriate general category for investor-focused news that doesn't fit a specific financial report type is 'Regulatory Filings' (RNS), as it is a formal dissemination of corporate news via a service like DGAP/EQS.
2020-11-04 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.